Tower Research Capital LLC (TRC) - NEUROBO PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

NEUROBO PHARMACEUTICALS INC's ticker is and the CUSIP is 64132R206.

Links
Filings
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,878
+21.7%
12,348
+11.8%
0.00%–
Q2 2023$4,828
+120600.0%
11,047
+105.1%
0.00%–
Q1 2023$40.0%5,3850.0%0.00%–
Q4 2022$4
-99.8%
5,385
+2925.3%
0.00%–
Q3 2022$2,000–178–0.00%–
 Download
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Virtu Financial LLC 23,869$100.00%
BANK OF AMERICA CORP /DE/ 8$30.00%
WELLS FARGO & COMPANY/MN 104$450.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
TWO SIGMA INVESTMENTS, LP 12,487$5,4580.00%
BlackRock Inc. 42,220$18,4540.00%
Tower Research Capital LLC (TRC) 11,047$4,8280.00%
MORGAN STANLEY 2$10.00%
Federation des caisses Desjardins du Quebec 5$20.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders